Astral Limited enters its Q1 FY27 results following a quarter of volatile PVC resin prices and mixed demand signals across its plumbing and infrastructure segments. Investors will be focused on whether the company's volume trajectory held up against a soft industry backdrop and how recent price protection measures impacted its consolidated EBITDA margin.
| Results date | August 12, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Previous quarter revenue | Rs. 2,088.5 Cr |
| Previous quarter PAT | Rs. 213.0 Cr |
| Previous quarter EBITDA margin | 19.2% |
| Market cap | Rs. 38793.08 Cr |
| CMP | Rs. 1444.0 |
The board meeting is scheduled for August 12, 2026, to approve the unaudited Q1 FY27 financial results.
The earnings call is scheduled for August 12, 2026, at 5:00 PM IST with the management team including Sandeep Engineer (CMD), Hiranand Savlani (ED & CFO), Kairav Engineer (ED), and Saumya Engineer (CEO – Adhesive & Paint).
Astral's Q1 FY27 performance is likely to reflect a challenging start to the fiscal year, with revenue growth expected to trail the management's 20–25% aspirational target due to channel destocking and soft agricultural demand. While PVC resin prices corrected ~25% during the quarter, Reliance's price protection measures are expected to cushion the inventory loss impact compared to the Rs. 25 Cr hit seen in Q1 FY26. Margin compression is anticipated sequentially from the seasonally strong Q4 FY26, driven by revenue de-leverage and fixed costs from recent capacity expansions like the Hyderabad plant, which operated at 50–55% utilization entering the year. Looking ahead, management's commentary on the 16–18% EBITDA margin guidance for FY27 and the progress of the CPVC resin plant, which is targeting trial runs by Q3 FY27, will be critical for assessing the trajectory for the remainder of the year.
Performance vs Guidance Tracking: Tracking progress against management's stated FY27 goals.
CPVC Resin Plant Progress: Monitoring the status of the 40,000 MTPA Dahej facility.
Chemicals Business & Demerger: Updates following the withdrawal of the Composite Scheme of Arrangement.
Operating metric trajectory: Key segment performance indicators.
Risks and headwinds to monitor: Management-flagged operational challenges.
In Q3 FY26, management disclosed an inventory loss of Rs. 20–25 Cr due to declining PVC/CPVC prices. Similarly, in Q1 FY26, a Rs. 25 Cr inventory loss contributed to a decline in the consolidated EBITDA margin to 14.25%.
The board withdrew the Composite Scheme of Arrangement on July 29, 2026, after an independent consultant recommended against proceeding due to the current scale of the business. Management indicated that the demerger may be reconsidered in the future when the business achieves sufficient scale.
While Astral achieved 12–13% volume growth in the first nine months of FY26, the start to FY27 has been soft. Analysts expect Q1 FY27 volume growth to be around 2%, which is significantly behind the company's double-digit volume growth commitment for the full year.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now